AU1323897A - Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads - Google Patents

Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads

Info

Publication number
AU1323897A
AU1323897A AU13238/97A AU1323897A AU1323897A AU 1323897 A AU1323897 A AU 1323897A AU 13238/97 A AU13238/97 A AU 13238/97A AU 1323897 A AU1323897 A AU 1323897A AU 1323897 A AU1323897 A AU 1323897A
Authority
AU
Australia
Prior art keywords
controlled release
release beads
furosemide
formulation containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13238/97A
Inventor
Hans Arwidsson
Maria Eriksson
Lars Stubberud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU1323897A publication Critical patent/AU1323897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13238/97A 1996-01-05 1996-12-20 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads Abandoned AU1323897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600046A SE9600046D0 (en) 1996-01-05 1996-01-05 New pharmaceutical formulation
SE9600046 1996-01-05
PCT/SE1996/001734 WO1997025028A1 (en) 1996-01-05 1996-12-20 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads

Publications (1)

Publication Number Publication Date
AU1323897A true AU1323897A (en) 1997-08-01

Family

ID=20400947

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13238/97A Abandoned AU1323897A (en) 1996-01-05 1996-12-20 Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads

Country Status (7)

Country Link
AU (1) AU1323897A (en)
HR (1) HRP970004A2 (en)
MA (1) MA26416A1 (en)
SE (1) SE9600046D0 (en)
TN (1) TNSN97001A1 (en)
WO (1) WO1997025028A1 (en)
ZA (1) ZA9610888B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070051953A (en) 1998-11-02 2007-05-18 엘란 코포레이션, 피엘씨 Multiparticulate modified release composition
FR2796840B1 (en) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
HU230828B1 (en) 1999-10-29 2018-08-28 Euro Celtique Sa Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN101317825A (en) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 Controlled release hydrocodone formulations
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
EP1669074B1 (en) * 2004-12-01 2010-06-02 Par Pharmaceuticals, Inc. Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
WO2009145716A1 (en) * 2008-05-28 2009-12-03 Astrazeneca Ab New pharmaceutical formulation useful in gerd therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
CA1338596C (en) * 1988-09-27 1996-09-17 Hiroyoshi Koyama Granules having core and their production

Also Published As

Publication number Publication date
SE9600046D0 (en) 1996-01-05
WO1997025028A1 (en) 1997-07-17
HRP970004A2 (en) 1998-04-30
MA26416A1 (en) 2004-12-20
TNSN97001A1 (en) 2005-03-15
ZA9610888B (en) 1997-07-07

Similar Documents

Publication Publication Date Title
ZA955545B (en) New beads for controlled release and a pharmaceutical preparation containing the same
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU6995396A (en) Pharmaceutical formulation
AU7499096A (en) Stable freeze-dried pharmaceutical formulation
AU6526896A (en) Substituted aromatic compounds and their pharmaceutical use
AU6973396A (en) Pharmaceutical formulation
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU2415299A (en) Substituted benzenesulfonamide derivatives and their pharmaceutical use
AU1323897A (en) Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads
AUPN801196A0 (en) New cephem compounds and pharmaceutical use thereof
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU7582696A (en) Pharmaceutical formulation
AU4123396A (en) Cephem compounds and pharmaceutical use thereof
AU5280396A (en) Pharmaceutical microencapsulation
AU6318896A (en) Benzamidoxime derivatives and medicinal use thereof
AU3709897A (en) Cathecol derivatives and a method for the preparation thereof and a pharmaceutical composition containing the same
AU5416898A (en) Cisplatinum comprising pharmaceutical
AU4964597A (en) Benzenesulfonamide derivatives and medicaments comprising said derivatives
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU3173897A (en) Polyol succinates and their pharmaceutical formulation
AU5997196A (en) A stabilized pharmaceutical formulation comprising growth ho rmone and lys-gly-asp-ser
AU8031698A (en) Indane compounds and their pharmaceutical use
AU7681498A (en) Pharmaceutical composition and use thereof
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof